What is Global Artesunate Tablet Market?
The Global Artesunate Tablet Market is a vast and dynamic sector that has been gaining significant attention in recent years. Artesunate tablets are a form of antimalarial medication that is widely used to treat severe malaria. This market revolves around the production, distribution, and sale of these tablets on a global scale. The market's value was estimated at US$ 159 million in 2022, and it is expected to grow to US$ 240.2 million by 2029. This growth is primarily driven by the increasing prevalence of malaria in various parts of the world, particularly in developing countries. The market's expansion is also fueled by the ongoing research and development activities aimed at improving the efficacy and safety of artesunate tablets. However, the market faces challenges such as stringent regulatory policies and the high cost of artesunate tablets. Despite these challenges, the Global Artesunate Tablet Market holds immense potential for growth and development in the coming years.
Monoaromatic Artesunate, Compound Artesunate in the Global Artesunate Tablet Market:
The Global Artesunate Tablet Market is segmented into Monoaromatic Artesunate and Compound Artesunate. Monoaromatic Artesunate is a type of artesunate that contains a single aromatic ring in its chemical structure. It is widely used in the treatment of severe malaria due to its high efficacy and minimal side effects. On the other hand, Compound Artesunate is a combination of artesunate with other antimalarial drugs. This combination is designed to enhance the effectiveness of the treatment and reduce the risk of drug resistance. The major players in the market, including Fosun Pharma (Guilin), Ipca Laboratories, Sanofi Aventis, Ajanta Pharma, Shin Poong, Cipla, Acino, and MCW Healthcare, account for about 70% of the market. These companies play a crucial role in shaping the market dynamics through their innovative products and strategic initiatives.
Hospital, Clinic, Others in the Global Artesunate Tablet Market:
The Global Artesunate Tablet Market finds its applications mainly in hospitals, clinics, and other healthcare settings. Hospitals account for over 67% of the market's application due to the high incidence of severe malaria cases that require hospitalization. Artesunate tablets are often the first line of treatment for these patients due to their high efficacy and rapid action. Clinics also form a significant part of the market as they are often the first point of contact for patients with mild to moderate malaria. Other applications of artesunate tablets include home care settings and pharmacies. Despite the varying applications, the common goal remains the same - to effectively treat malaria and reduce its burden on global health.
Global Artesunate Tablet Market Outlook:
The Global Artesunate Tablet Market outlook highlights the market's robust growth potential. The market was valued at US$ 159 million in 2022 and is expected to reach US$ 240.2 million by 2029, growing at a CAGR of 6.0% during the forecast period 2023-2029. The market's growth is driven by the increasing prevalence of malaria and the ongoing efforts to combat this disease. The major players in the market, including Fosun Pharma (Guilin), Ipca Laboratories, Sanofi Aventis, Ajanta Pharma, Shin Poong, Cipla, Acino, and MCW Healthcare, collectively account for about 70% of the market. The majority of the market's application is in hospitals, which account for over 67% of the market. This outlook provides a comprehensive overview of the market's current status and future prospects.
| Report Metric | Details |
| Report Name | Artesunate Tablet Market |
| Accounted market size in 2022 | US$ 159 in million |
| Forecasted market size in 2029 | US$ 240.2 million |
| CAGR | 6.0% |
| Base Year | 2022 |
| Forecasted years | 2023 - 2029 |
| Segment by Type |
|
| Segment by Application |
|
| Consumption by Region |
|
| By Company | Fosun Pharma (Guilin), Ipca Laboratories, Sanofi Aventis, Ajanta Pharma, Shin Poong, Cipla, Acino, MCW Healthcare |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
